Theravance Biopharma Inc (TBPH)

Nov 04, 2025

Theravance Biopharma (NASDAQ:TBPH) Sets New 12-Month HighWhat's Next? - MarketBeat

Nov 04, 2025

Nov 04, 2025

Theravance Biopharma Hits New 52-Week High of $15.34, Up 74.94% - Markets Mojo

Nov 04, 2025

Nov 04, 2025

Theravance Biopharma (TBPH) Expected to Announce Quarterly Earnings on Monday - MarketBeat

Nov 04, 2025

Nov 04, 2025

What momentum shifts mean for Theravance Biopharma Inc.July 2025 Action & Stepwise Trade Signal Implementation - newser.com

Nov 04, 2025

Nov 04, 2025

News impact scoring models applied to Theravance Biopharma Inc.Options Play & Free Growth Oriented Trading Recommendations - newser.com

Nov 04, 2025

Nov 04, 2025

Is Theravance Biopharma Inc. (0TB) stock a momentum leaderExit Point & Weekly Momentum Picks - newser.com

Nov 04, 2025

Nov 04, 2025

Can Theravance Biopharma Inc. (0TB) stock sustain revenue momentumMarket Risk Analysis & Fast Moving Trade Plans - newser.com

Nov 04, 2025

Nov 03, 2025

Can Theravance Biopharma Inc. stock attract ESG capital inflowsPortfolio Risk Report & Reliable Price Action Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Can Theravance Biopharma Inc. stock maintain operating margins2025 Stock Rankings & Weekly High Return Stock Opportunities - newser.com

Nov 03, 2025

Nov 03, 2025

Is Theravance Biopharma Inc. stock cheap at current valuationWeekly Stock Summary & Community Driven Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Why Theravance Biopharma Inc. stock is in analyst buy zone2025 Technical Patterns & Technical Confirmation Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Comparing Theravance Biopharma Inc. in custom built stock radarsRate Hike & Consistent Income Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Will a bounce in Theravance Biopharma Inc. offer an exitQuarterly Profit Review & Capital Efficiency Focused Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

Theravance Biopharma Inc. stock retracement – recovery analysisEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 03, 2025

Nov 03, 2025

What consensus target says about Theravance Biopharma Inc. (0TB) stockInflation Watch & Verified Short-Term Trading Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Can Theravance Biopharma Inc. stock deliver consistent earnings growthJuly 2025 Sentiment & Stepwise Trade Execution Plans - newser.com

Nov 03, 2025

Nov 02, 2025

What to expect from Theravance Biopharma Inc. in the next 30 daysJuly 2025 PostEarnings & Real-Time Volume Analysis - newser.com

Nov 02, 2025

Nov 02, 2025

Can Theravance Biopharma Inc. (0TB) stock hit consensus price targets2025 Price Targets & Safe Entry Trade Signal Reports - newser.com

Nov 02, 2025

Nov 02, 2025

Why Theravance Biopharma Inc. (0TB) stock benefits from AI revolutionMarket Performance Recap & Reliable Breakout Forecasts - newser.com

Nov 02, 2025

Nov 02, 2025

Why Theravance Biopharma Inc. (0TB) stock remains stableJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com

Nov 02, 2025

Nov 02, 2025

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Nov 02, 2025

Nov 02, 2025

Theravance Biopharma Inc. stock trendline breakdownJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Will Theravance Biopharma Inc. stock see insider buyingAnalyst Upgrade & Technical Pattern Based Signals - newser.com

Nov 02, 2025

Oct 31, 2025

How to escape a deep drawdown in Theravance Biopharma Inc.July 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com

Oct 31, 2025

Oct 30, 2025

Theravance Biopharma, Inc. (TBPH) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025

Oct 30, 2025

CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy? - sharewise.com

Oct 30, 2025